查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1591929

基于水凝胶的药物传输系统市场：按输送途径、聚合物来源划分 - 2025-2030 年全球预测

Hydrogel-based Drug Delivery System Market by Delivery Route (Ocular, Oral Cavity, Subcutaneous), Polymer Origin (Hybrid, Natural, Synthetic) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年水凝胶给药系统市值为75.1亿美元，预计2024年将达到81.5亿美元，复合年增长率为8.65%，到2030年将达到134亿美元，预计将达到2000万美元。

我们的以水凝胶为基础的药物传递系统系列包括创新的药物管理方法，利用水凝胶的生物相容性和高含水量来促进受控和持续的药物释放。这些系统至关重要，因为它们透过优化药物分布来提高治疗效果、减少副作用并提高患者的依从性。基于水凝胶的药物递送技术的应用涵盖经皮吸收贴片、眼科系统、口服递送和植入装置等多个领域，对于针对癌症、糖尿病和自体免疫疾病的药物我们是相容的。对于最终用途，这些系统主要由製药公司、研究机构和医院使用。

主要市场统计
基准年[2023] 75.1亿美元
预测年份 [2024] 81.5亿美元
预测年份 [2030] 134.2亿美元
复合年增长率（%） 8.65%

市场成长受到慢性病盛行率增加、水凝胶技术进步以及对标靶药物传递方法的需求增加等因素的显着影响。该领域的主要商机包括生物技术和材料科学的持续进步，以开发个人化医疗选择并扩大在基因和蛋白质治疗方面的应用。市场参与者可以透过关注能够响应温度和 pH 值等环境刺激的智慧水凝胶并投资于增强水凝胶性能的研究来抓住这些机会。

然而，高昂的开发成本、监管障碍和潜在的生物相容性问题等挑战是市场扩张的障碍。应对这些挑战需要与监管机构进行策略合作，以简化核准流程并进行严格的研究和开发，以确保安全性和有效性。最佳创新领域包括探索生物可吸收水凝胶和多模态载药水凝胶，以实现治疗应用多样化。

市场是动态的，其特点是竞争格局、不断的技术创新和激烈的研发活动。寻求发展业务的公司正在寻求技术交流和研究合作的合作伙伴，同时紧跟新趋势，例如使用水凝胶基质进行 3D 生物列印，并投资于强有力的临床试验来检验新应用。

市场动态：快速发展的水凝胶给药系统市场的关键市场洞察

基于水凝胶的药物传输系统市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 对标靶控制药物输送 (TCDD) 的需求不断增长
    • 水凝胶因其优异的物理特性
  • 市场限制因素
    • 机械强度低，相容性问题
  • 市场机会
    • 各大製药公司加大对研发活动的投入与资助
    • 药品生产中需要提高生物相容性和生物分解性的技术
  • 市场挑战
    • 水凝胶高成本

波特五力：驾驭水凝胶给药系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解对水凝胶给药系统市场的外部影响

外部宏观环境因素在塑造水凝胶给药系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解水凝胶给药系统市场的竞争格局

对基于水凝胶的药物传输系统市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵水凝胶给药系统市场供应商的绩效评估

FPNV定位矩阵是评估水凝胶给药系统市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划水凝胶给药系统市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，基于水凝胶的药物传输系统市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对标靶控制药物输送 (TCDD) 的需求不断增加
      • 水凝胶具有优异的物理性能
    • 抑制因素
      • 机械强度低和相容性问题
    • 机会
      • 各大製药公司加大对研发活动的投入与资助
      • 药品製造中需要改进的生物相容性和生物分解性技术
    • 任务
      • 水凝胶高成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以水凝胶为基础的药物传输系统市场（以输送路径）

  • 眼科
  • 口腔
  • 皮下的
  • 话题

第七章以水凝胶为基础的药物传递系统市场聚合物起源

  • 混合
  • 自然的
  • 合成

第八章美洲水凝胶给药系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区水凝胶给药系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲水凝胶给药系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Akorn, Incorporated
  • Ashland
  • B. Braun Holding GmbH & Co. KG
  • Bausch and Lomb
  • Blairex Laboratories, Inc.
  • Cardinal Health
  • Endo International plc
  • Ferring BV
  • GALDERMA
  • Johnson & Johnson
  • Medline Industries
  • Medtronic
  • Ocular Therapeutix, Inc.
  • Paul Hartmann
  • Smith & Nephew plc.
  • The Cooper Companies
  • Tolmar Pharmaceuticals, Inc
Product Code: MRR-3E7F10ED1C39

The Hydrogel-based Drug Delivery System Market was valued at USD 7.51 billion in 2023, expected to reach USD 8.15 billion in 2024, and is projected to grow at a CAGR of 8.65%, to USD 13.42 billion by 2030.

The scope of hydrogel-based drug delivery systems encompasses an innovative approach to medication administration, capitalizing on the biocompatibility and high water content of hydrogels to facilitate controlled and sustained drug release. These systems are crucial because they enhance therapeutic efficacy, reduce side effects, and improve patient compliance by optimizing drug distribution. The application of hydrogel-based drug delivery technology spans across diverse areas, including transdermal patches, ocular systems, oral delivery, and implantable devices, catering to pharmaceuticals targeting cancer, diabetes, and autoimmune diseases, among others. In terms of end-use, these systems are predominantly employed by pharmaceutical companies, research institutes, and hospitals.

KEY MARKET STATISTICS
Base Year [2023] USD 7.51 billion
Estimated Year [2024] USD 8.15 billion
Forecast Year [2030] USD 13.42 billion
CAGR (%) 8.65%

Market growth is significantly influenced by factors such as increasing prevalence of chronic diseases, advancements in hydrogel technology, and rising demand for targeted drug delivery methods. Key opportunities in the sector include the development of personalized medicine options and expanding applications in gene and protein therapy, driven by ongoing advancements in biotechnology and material science. Market players can seize these opportunities by investing in research to enhance hydrogel properties, focusing on smart hydrogels that respond to environmental stimuli like temperature and pH.

However, challenges such as the high cost of development, regulatory hurdles, and potential biocompatibility issues pose barriers to market expansion. Addressing these challenges requires strategic collaboration with regulatory bodies to streamline approval processes and rigorous R&D to ensure safety and efficacy. Best areas of innovation include exploring bioresorbable hydrogels and multimodal drug-loaded hydrogels to diversify therapeutic applications.

The market is dynamic, characterized by continuous technological breakthroughs and a competitive landscape with intense R&D activities. Companies aiming for business growth should focus on partnerships and collaborations for technology exchange, while keeping abreast of emerging trends, such as 3D bioprinting with hydrogel matrices and investing in robust clinical trials to validate novel applications.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hydrogel-based Drug Delivery System Market

The Hydrogel-based Drug Delivery System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising upsurge in the need of targeted controlled drug delivery (TCDD)
    • Hydrogel owing to its excellent physical properties
  • Market Restraints
    • Low mechanical strength, and compatibility issues
  • Market Opportunities
    • Increasing investment and funding by leading pharma companies in R&D activities
    • Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
  • Market Challenges
    • High cost of hydrogels

Porter's Five Forces: A Strategic Tool for Navigating the Hydrogel-based Drug Delivery System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hydrogel-based Drug Delivery System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Hydrogel-based Drug Delivery System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hydrogel-based Drug Delivery System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Hydrogel-based Drug Delivery System Market

A detailed market share analysis in the Hydrogel-based Drug Delivery System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hydrogel-based Drug Delivery System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hydrogel-based Drug Delivery System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Hydrogel-based Drug Delivery System Market

A strategic analysis of the Hydrogel-based Drug Delivery System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Hydrogel-based Drug Delivery System Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Akorn, Incorporated, Ashland, B. Braun Holding GmbH & Co. KG, Bausch and Lomb, Blairex Laboratories, Inc., Cardinal Health, Endo International plc, Ferring B.V., GALDERMA, Johnson & Johnson, Medline Industries, Medtronic, Ocular Therapeutix, Inc., Paul Hartmann, Smith & Nephew plc., The Cooper Companies, and Tolmar Pharmaceuticals, Inc.

Market Segmentation & Coverage

This research report categorizes the Hydrogel-based Drug Delivery System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Delivery Route, market is studied across Ocular, Oral Cavity, Subcutaneous, and Topical.
  • Based on Polymer Origin, market is studied across Hybrid, Natural, and Synthetic.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising upsurge in the need of targeted controlled drug delivery (TCDD)
      • 5.1.1.2. Hydrogel owing to its excellent physical properties
    • 5.1.2. Restraints
      • 5.1.2.1. Low mechanical strength, and compatibility issues
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing investment and funding by leading pharma companies in R&D activities
      • 5.1.3.2. Need of Improved biocompatibility and biodegradability technologies for drug manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of hydrogels
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Hydrogel-based Drug Delivery System Market, by Delivery Route

  • 6.1. Introduction
  • 6.2. Ocular
  • 6.3. Oral Cavity
  • 6.4. Subcutaneous
  • 6.5. Topical

7. Hydrogel-based Drug Delivery System Market, by Polymer Origin

  • 7.1. Introduction
  • 7.2. Hybrid
  • 7.3. Natural
  • 7.4. Synthetic

8. Americas Hydrogel-based Drug Delivery System Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Hydrogel-based Drug Delivery System Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Hydrogel-based Drug Delivery System Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Akorn, Incorporated
  • 3. Ashland
  • 4. B. Braun Holding GmbH & Co. KG
  • 5. Bausch and Lomb
  • 6. Blairex Laboratories, Inc.
  • 7. Cardinal Health
  • 8. Endo International plc
  • 9. Ferring B.V.
  • 10. GALDERMA
  • 11. Johnson & Johnson
  • 12. Medline Industries
  • 13. Medtronic
  • 14. Ocular Therapeutix, Inc.
  • 15. Paul Hartmann
  • 16. Smith & Nephew plc.
  • 17. The Cooper Companies
  • 18. Tolmar Pharmaceuticals, Inc

LIST OF FIGURES

  • FIGURE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET RESEARCH PROCESS
  • FIGURE 2. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET DYNAMICS
  • TABLE 7. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY OCULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY ORAL CAVITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY HYBRID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY DELIVERY ROUTE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SIZE, BY POLYMER ORIGIN, 2018-2030 (USD MILLION)
  • TABLE 102. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. HYDROGEL-BASED DRUG DELIVERY SYSTEM MARKET, FPNV POSITIONING MATRIX, 2023